168 related articles for article (PubMed ID: 2440221)
1. Humoral-dependent hemopoiesis and flow cytometric analysis of chronic myelogenous leukemia in erythroblastic transformation.
Lutton JD; Chiao JW; Ascensao JL; Atamer M; Arlin Z; Levere RD
Acta Haematol; 1987; 77(2):120-3. PubMed ID: 2440221
[TBL] [Abstract][Full Text] [Related]
2. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
[TBL] [Abstract][Full Text] [Related]
3. Factors and hemopoiesis: Pandora's box revisited.
Eaves CJ; Eaves AC
Prog Clin Biol Res; 1984; 148():83-92. PubMed ID: 6379675
[No Abstract] [Full Text] [Related]
4. In vitro response to erythropoietin in erythroblastic transformation of chronic myelogenous leukemia.
Greenberg BR; Hirasuna JD; Woo L
Exp Hematol; 1980 Jan; 8(1):52-6. PubMed ID: 6931816
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte/macrophage progenitor cells from peripheral blood and bone marrow differ in their response to prostaglandin E1.
Richman CM; Johnson GD
Blood; 1987 Dec; 70(6):1792-6. PubMed ID: 3499944
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of CD34 (My10)-positive myeloid and erythroid progenitors from human marrow and their growth in cultures supplemented with recombinant human granulocyte-macrophage colony-stimulating factor.
Baines P; Mayani H; Bains M; Fisher J; Hoy T; Jacobs A
Exp Hematol; 1988 Oct; 16(9):785-9. PubMed ID: 2458955
[TBL] [Abstract][Full Text] [Related]
7. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.
Barak Y; Hahn T; Pecht M; Karov Y; Berrebi A; Zaizov R; Stark B; Buchner V; Burstein Y; Trainin N
Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
9. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
[TBL] [Abstract][Full Text] [Related]
10. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
11. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
[TBL] [Abstract][Full Text] [Related]
12. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
Greenberg P; Mara B; Bax I; Brossel R; Schrier S
Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML).
Eaves AC; Eaves CJ
Exp Hematol; 1979; 7 Suppl 5():65-75. PubMed ID: 299448
[TBL] [Abstract][Full Text] [Related]
15. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
Robak T; Hast R; Goldman JM
Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
[TBL] [Abstract][Full Text] [Related]
16. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
17. Hemopoietic precursor cells in erythroleukemia.
Suda T; Miura Y; Ozawa K; Mizoguchi H; Takaku F
Stem Cells (1981); 1982; 1(4-5):224-32. PubMed ID: 6959295
[TBL] [Abstract][Full Text] [Related]
18. Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports formation of GM and multipotential blast cell colonies in culture: comparison with the effects of interleukin-3.
Koike K; Ogawa M; Ihle JN; Miyake T; Shimizu T; Miyajima A; Yokota T; Arai K
J Cell Physiol; 1987 Jun; 131(3):458-64. PubMed ID: 3298286
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
20. Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells.
Metcalf D; Nicola NA
J Cell Physiol; 1983 Aug; 116(2):198-206. PubMed ID: 6602806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
